Autonomix Medical, Inc. (AMIX) stock
AMIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$1.37+0.02 (+1.11%)
Close on Nov 13, 2026Market cap $1.33MP/E –Yield –
Autonomix Medical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Autonomix Medical's EPS for the twelve months ending Sep 30, 2026 was -$8.12.
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | -$2.51 | – |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$5.02 | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$0.23 | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$0.36 | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$29.02 | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$22.69 | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$4.15 | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$1.46 | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$2.27 | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$2.20 | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$13.26 | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$3.10 | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$8.78 | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$0.91 | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$0.73 | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$0.68 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?